Neoadjuvant chemotherapy for breast cancer—background for the indication of locoregional treatment

David Krug; René Baumann; Wilfried Budach; Jürgen Dunst; Petra Feyer; Rainer Fietkau; Wulf Haase; Wolfgang Harms; Thomas Hehr; Marc D. Piroth; Felix Sedlmayer; Rainer Souchon; Frederik Wenz; Rolf Sauer

doi:10.1007/s00066-018-1329-8

Neoadjuvant chemotherapy for breast cancer—background for the indication of locoregional treatment

David Krug, René Baumann, Wilfried Budach, Jürgen Dunst, Petra Feyer, Rainer Fietkau, Wulf Haase, Wolfgang Harms, Thomas Hehr, Marc D. Piroth, Felix Sedlmayer, Rainer Souchon, Frederik Wenz, Rolf Sauer

Klinik für Strahlentherapie

18 Zitate (Scopus)

Abstract

© 2018, Springer-Verlag GmbH Germany, part of Springer Nature. Neoadjuvant chemotherapy (NACT) has been widely adopted into the multidisciplinary management of breast cancer. The prognostic impact of treatment response has been clearly demonstrated. However, the impact of treatment response on the indication for adjuvant radiotherapy is unclear. This review summarizes important implications of NACT and treatment response on the risk of recurrence and locoregional multidisciplinary management from the standpoint of radiation oncology.

Originalsprache	Englisch
Zeitschrift	Strahlentherapie und Onkologie
Jahrgang	194
Ausgabenummer	9
Seiten (von - bis)	797-805
Seitenumfang	9
ISSN	0179-7158
DOIs	https://doi.org/10.1007/s00066-018-1329-8
Publikationsstatus	Veröffentlicht - 01.09.2018

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Dokumente

10.1007/s00066-018-1329-8

Weitere Links

Link to publication in Scopus

Zitieren

@article{b29db8e12f284777958f6e712c5794e9,

title = "Neoadjuvant chemotherapy for breast cancer—background for the indication of locoregional treatment",

abstract = "{\textcopyright} 2018, Springer-Verlag GmbH Germany, part of Springer Nature. Neoadjuvant chemotherapy (NACT) has been widely adopted into the multidisciplinary management of breast cancer. The prognostic impact of treatment response has been clearly demonstrated. However, the impact of treatment response on the indication for adjuvant radiotherapy is unclear. This review summarizes important implications of NACT and treatment response on the risk of recurrence and locoregional multidisciplinary management from the standpoint of radiation oncology.",

author = "David Krug and Ren{\'e} Baumann and Wilfried Budach and J{\"u}rgen Dunst and Petra Feyer and Rainer Fietkau and Wulf Haase and Wolfgang Harms and Thomas Hehr and Piroth, \{Marc D.\} and Felix Sedlmayer and Rainer Souchon and Frederik Wenz and Rolf Sauer",

year = "2018",

month = sep,

day = "1",

doi = "10.1007/s00066-018-1329-8",

language = "English",

volume = "194",

pages = "797--805",

journal = "Strahlentherapie und Onkologie",

issn = "0179-7158",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "9",

}

TY - JOUR

T1 - Neoadjuvant chemotherapy for breast cancer—background for the indication of locoregional treatment

AU - Krug, David

AU - Baumann, René

AU - Budach, Wilfried

AU - Dunst, Jürgen

AU - Feyer, Petra

AU - Fietkau, Rainer

AU - Haase, Wulf

AU - Harms, Wolfgang

AU - Hehr, Thomas

AU - Piroth, Marc D.

AU - Sedlmayer, Felix

AU - Souchon, Rainer

AU - Wenz, Frederik

AU - Sauer, Rolf

PY - 2018/9/1

Y1 - 2018/9/1

N2 - © 2018, Springer-Verlag GmbH Germany, part of Springer Nature. Neoadjuvant chemotherapy (NACT) has been widely adopted into the multidisciplinary management of breast cancer. The prognostic impact of treatment response has been clearly demonstrated. However, the impact of treatment response on the indication for adjuvant radiotherapy is unclear. This review summarizes important implications of NACT and treatment response on the risk of recurrence and locoregional multidisciplinary management from the standpoint of radiation oncology.

AB - © 2018, Springer-Verlag GmbH Germany, part of Springer Nature. Neoadjuvant chemotherapy (NACT) has been widely adopted into the multidisciplinary management of breast cancer. The prognostic impact of treatment response has been clearly demonstrated. However, the impact of treatment response on the indication for adjuvant radiotherapy is unclear. This review summarizes important implications of NACT and treatment response on the risk of recurrence and locoregional multidisciplinary management from the standpoint of radiation oncology.

UR - https://www.scopus.com/pages/publications/85049583566

U2 - 10.1007/s00066-018-1329-8

DO - 10.1007/s00066-018-1329-8

M3 - Scientific review articles

C2 - 29974132

AN - SCOPUS:85049583566

SN - 0179-7158

VL - 194

SP - 797

EP - 805

JO - Strahlentherapie und Onkologie

JF - Strahlentherapie und Onkologie

IS - 9

ER -

Neoadjuvant chemotherapy for breast cancer—background for the indication of locoregional treatment

Abstract

UN SDGs

Dokumente

Weitere Links

Fingerprint

Zitieren